PrecisionLife: Absci, PrecisionLife Partner to Develop AI-Enabled Drug Pipeline

What You Should Know: - Absci, a generative AI drug creation company, and PrecisionLife, a pioneer in computational biology for complex chronic diseases, have announced a powerful partnership to develop a joint portfolio of potential therapeutics. - This collaboration aims to leverage the strengths of both companies to address unmet medical needs and accelerate drug ... Read More